Japan · 
Who invested in Surv Biopharma?
Surv Biopharma's investors include B Capital, Nippon Venture Capital, Kyoto University Innovation Capital Co., Ltd, FFG Venture Business Partners and Keio Innovation Initiative.
2026
$9.7MSeries B$17MGrantJapan · Funded startup
Who invested in Surv Biopharma
Funding summaryUpdated 26 Oct 2026
$27Mraised across 2 rounds since 2025, from 2 sources
$9.7MSeries B$17MGrant
- Latest round
- Grant, $17MDec 2025
- Step-upi
- 1.8×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $9.7M Nov 2025
- Biggest round
- $17M Grant · Dec 2025
The rounds
- Dec 2025Grant$17M2 new
Source recorded
- Nov 2025
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
FFG Venture Business PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Surv Biopharma
How much has Surv Biopharma raised?
Surv Biopharma has raised $27M across 2 rounds since 2025.
When did Surv Biopharma last raise?
Surv Biopharma's most recent round was a Grant of $17M in Dec 2025.
What was Surv Biopharma's biggest round?
Its most recent round, $17M in Dec 2025, is also its largest on record.
Who backed Surv Biopharma first?
Surv Biopharma's first round on record, in Nov 2025, was backed by B Capital, Nippon Venture Capital and Keio Innovation Initiative.
What stage is Surv Biopharma at?
Surv Biopharma's latest named round is a Grant, in Dec 2025.
Where is Surv Biopharma based?
Surv Biopharma is based in Japan.
Companies like Surv Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.